Details for New Drug Application (NDA): 020860
✉ Email this page to a colleague
NDA 020860 describes LEVLITE, which is a drug marketed by Bayer Hlthcare and is included in one NDA. Additional details are available on the LEVLITE profile page.
The generic ingredient in LEVLITE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
The generic ingredient in LEVLITE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for 020860
| Tradename: | LEVLITE |
| Applicant: | Bayer Hlthcare |
| Ingredient: | ethinyl estradiol; levonorgestrel |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.02MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 13, 1998 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-28 | Strength | 0.02MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 13, 1998 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
